The statement that 'if approved, shareholders of Alkane will have the same proportional ownership in both Alkane and ASM, with the exception of Ineligible Foreign Shareholders (refer to the upcoming Demerger Booklet for details relating to investors with registered addresses outside of Australia and New Zealand)' concerns me..
I'm domiciled in the UK. Does anyone have any knowledge from precedence on whether this affects all foreign shareholders or might just apply to US investors who seem to have some onerous restrictions?
Any insights will be appreciated. I'll drop a line to investor relations also.
- Forums
- ASX - By Stock
- Ann: ALK and Aust. Strategic Materials progress towards Demerger
The statement that 'if approved, shareholders of Alkane will...
Featured News
Add ALK (ASX) to my watchlist
(20min delay)
|
|||||
Last
49.5¢ |
Change
-0.025(4.81%) |
Mkt cap ! $299.5M |
Open | High | Low | Value | Volume |
50.0¢ | 50.0¢ | 48.0¢ | $731.1K | 1.485M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 33631 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.5¢ | 12456 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 33631 | 0.490 |
2 | 12800 | 0.485 |
4 | 113156 | 0.480 |
2 | 40000 | 0.475 |
6 | 127015 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.495 | 12456 | 3 |
0.500 | 21800 | 2 |
0.505 | 7800 | 1 |
0.515 | 2015 | 1 |
0.520 | 53288 | 5 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ALK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online